NuVasive Inc. (NUVA)

58.54
0.04 0.07
NASDAQ : Health Technology
Prev Close 58.50
Open 58.82
Day Low/High 58.43 / 59.73
52 Wk Low/High 43.51 / 72.41
Volume 604.20K
Avg Volume 678.90K
Exchange NASDAQ
Shares Outstanding 51.42M
Market Cap 2.97B
EPS 1.60
P/E Ratio 120.48
Div & Yield N.A. (N.A)

Latest News

Trade Talks, Shutdown, NuVasive, Activision, Amazon - 5 Things You Must Know

Trade Talks, Shutdown, NuVasive, Activision, Amazon - 5 Things You Must Know

U.S. stock futures are higher as U.S.-China trade talks resume; Republican and Democratic lawmakers are working to broker an agreement that will prevent another government shutdown on Friday; Smith & Nephew reportedly has held talks to buy NuVasive; Activision could announce job cuts when it reports earnings Tuesday.

NuVasive Announces Conference Call And Webcast Of Fourth Quarter And Full Year 2018 Results

NuVasive Announces Conference Call And Webcast Of Fourth Quarter And Full Year 2018 Results

SAN DIEGO, Jan. 29, 2019 /PRNewswire/ -- NuVasive, Inc.

NuVasive Announces Preliminary Unaudited Fourth Quarter And Full Year 2018 Revenue Results

NuVasive Announces Preliminary Unaudited Fourth Quarter And Full Year 2018 Revenue Results

SAN DIEGO, Jan. 7, 2019 /PRNewswire/ -- NuVasive, Inc.

NuVasive CEO J. Christopher Barry Announces New Organizational Structure And Leadership Team

NuVasive CEO J. Christopher Barry Announces New Organizational Structure And Leadership Team

SAN DIEGO, Jan. 3, 2019 /PRNewswire/ -- NuVasive, Inc.

NuVasive To Participate In 37th Annual J.P. Morgan Healthcare Conference

NuVasive To Participate In 37th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 27, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Grows Cervical Spinal Interbody Portfolio With PEEK Corpectomy Implant

NuVasive Grows Cervical Spinal Interbody Portfolio With PEEK Corpectomy Implant

Company receives FDA 510(k) clearance for expanded use of Monolith® Corpectomy System, introducing fully modular PEEK implant indicated for use in the cervical spine

NuVasive To Participate In The 30th Annual Piper Jaffray Healthcare Conference

NuVasive To Participate In The 30th Annual Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 19, 2018 /PRNewswire/ -- NuVasive, Inc.

Biglari Holdings Doesn’t Look Appetizing, Plus 4 Other Good Short Candidates

BH, ENLK, R, DVN and NUVA were all recently downgraded by TheStreet’s Quant Ratings service.

NuVasive's Proprietary Porous PEEK™ Implant To Be Used In Flagship XLIF® Procedure

NuVasive's Proprietary Porous PEEK™ Implant To Be Used In Flagship XLIF® Procedure

Company receives FDA 510(k) clearance for use of COHERE® interbody in XLIF® procedure as new clinical study further validates important benefits of Porous PEEK™ material technology

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BXMT, CHK, CHMI, CWEN, CWEN.A, EBMT, EFC, HASI, HIIQ, HMST, HTBI, HY, HZNP, JTPY, KNDI, LARK, LMRK, MBI, MFNC, MFSF, PBFX, RC, TEUM, UBNK, URG Downgrades: APTV, CFBK, CNFR, CPLP, CVEO, HF, HNGR, HPJ, IAG, INS, LGL, MAA, MCRN, MDRX, MHH, MTLS, NFBK, NUVA, OFED, OMI, VTSI, WNC, WSTL Initiations: I, ONS Read on to get TheStreet Quant Ratings' detailed report:

NuVasive Reports Third Quarter 2018 Financial Results

NuVasive Reports Third Quarter 2018 Financial Results

SAN DIEGO, Oct. 30, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Announces Conference Call And Webcast Of Third Quarter 2018 Results

NuVasive Announces Conference Call And Webcast Of Third Quarter 2018 Results

SAN DIEGO, Oct. 11, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Announces Strategic Partnership With Biedermann Technologies To Access Intellectual Property And Co-Develop State-of-the-Art Complex Spine Solutions

NuVasive Announces Strategic Partnership With Biedermann Technologies To Access Intellectual Property And Co-Develop State-of-the-Art Complex Spine Solutions

Biedermann Technologies' leading innovations to be available with NuVasive's RELINE® posterior fixation system to create differentiated adult and pediatric technology solutions

NuVasive Clinical Services Awarded Sole Source Intraoperative Neuromonitoring Services Contract With Premier

NuVasive Clinical Services Awarded Sole Source Intraoperative Neuromonitoring Services Contract With Premier

SAN DIEGO, Oct. 8, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive To Showcase Comprehensive Solutions For Complex Spinal Deformities At Scoliosis Research Society Annual Meeting

NuVasive To Showcase Comprehensive Solutions For Complex Spinal Deformities At Scoliosis Research Society Annual Meeting

New technologies launched to expand deformity portfolio to address additional pediatric and adult patients' clinical needs

NuVasive To Demonstrate Pulse™ Surgical Automation Platform At NASS 2018 Annual Meeting

NuVasive To Demonstrate Pulse™ Surgical Automation Platform At NASS 2018 Annual Meeting

Initial Pulse Alpha Trial Results Show Extensive Clinical Utility in Nearly all Spine Surgery Cases and Workflow Efficiencies Intended to Reduce Operating Room Time for Surgeon and Patient

NuVasive Expands Biologics Portfolio To Meet Clinical And Economic Needs

NuVasive Expands Biologics Portfolio To Meet Clinical And Economic Needs

SAN DIEGO, Sept. 24, 2018 /PRNewswire/ -- NuVasive, Inc.

Scott Huennekens To Join NuVasive Board Of Directors

Scott Huennekens To Join NuVasive Board Of Directors

New board appointment brings expertise in surgical robotics, data analytics and medical device commercialization

NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018

NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018

SAN DIEGO, Sept. 20, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive To Present At The Morgan Stanley 16th Annual Global Healthcare Conference

NuVasive To Present At The Morgan Stanley 16th Annual Global Healthcare Conference

SAN DIEGO, Sept. 6, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX® 20 Degree Implant

NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX® 20 Degree Implant

SAN DIEGO, Sept. 5, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

SAN DIEGO, Sept. 4, 2018 /PRNewswire/ -- NuVasive, Inc.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHEF, CLH, DYSL, FLR, FORM, GPOR, HI, IBM, KBR, KW, NUVA, TGE, WSTL, X Downgrades: EMKR, PSMT, SEB Initiations: APPN, APRN, GDI Read on to get TheStreet Quant Ratings' detailed report:

First Week of May 18th Options Trading For Nuvasive Inc (NUVA)

First Week of May 18th Options Trading For Nuvasive Inc (NUVA)

Investors in Nuvasive Inc saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NUVA options chain for the new May 18th contracts and identified one put and one call contract of particular interest.

TheStreet Quant Rating: C (Hold)